Posted 1 week ago

Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) is seeing shares rise this morning on news that its Phase III data showed Tasimelteon significantly improves sleep in patients with chronic insomnia. The p

Tags: phase

Posted 1 week ago

We ran a screen of the top five NASDAQ biotech stocks by market cap to look at the short interest changes from the end of May to mid-June. Amgen Inc. (NASDAQ: AMGN) had the largest gains in short se

Tags: biotech short selling

Posted 1 week ago

Roche Holdings Ltd. appears to have lost some protection on Valganciclovir HCl. The FDA has granted Ranbaxy Laboratories Ltd. tentative approval to manufacture and market Valganciclovir Hydrochl

Posted 1 week ago

JPMorgan has come out with a relatively lackluster coverage in the Big Pharma sector, although not all calls are cautious.Bristol-Myers Squibb (NYSE: BMY), Eli Lilly & Co. (NYSE: LLY), Pfizer Inc. (NY

Tags: pharma

Posted 1 week ago

ImClone Systems Inc. (NASDAQ: IMCL) has announced that its Phase 1 clinical trial of IMC-A12, itss fully human IgG1 anti-insulin-like growth factor-1 receptor monoclonal antibody plus the mTOR inhibit

Tags: clinical trial phase

Posted 1 week ago

Eli Lilly & Co. (NYSE: LLY) is following the lead of Pfizer . in need of a new breed of drugs, and with shares on the 52-week low list and on a multi-year low list.The FDA has pushed back a decision

Posted 1 week ago

Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) have finalized their license and collaboration agreement for mipomersen, a novel lipid-lowering drug discovered and developed

Tags: phase

Posted 1 week ago

BNP Paribas overseas has lowered ratings of AstraZeneca (NYSE: AZN) to Underperform from Neutral; and raised Novartis (NYSE: NVS) to Neutral from Underperform.Goldman Sachs has raised Novo Nordisk (NY

Posted 1 week ago

We don t normally cover Canadian small cap biotechs or drug stocks up north, but sometimes money is money. Microbix Biosystems Inc. (MBX - TO) shares we up about 8% to C$0.87 on last look (2:40 PM

Posted 1 week ago

Barrier Therapeutics, Inc. (NASDAQ:BTRX) is seeing shares surge after it has signed a merger agreement with Stiefel Laboratories, Inc., the world s largest independent pharmaceutical company special